Antibody variants and fragments thereof

Details for Australian Patent Application No. 2003252758 (hide)

Owner Genentech, Inc.

Inventors Mulkerrin, Michael George; Shields, Robert Laird; Idusogie, Esohe Ekinaduese; Presta, Leonard G

Agent Griffith Hack

Pub. Number AU-B-2003252758

Parent 33699

Filing date 3 October 2003

Wipo publication date 6 November 2003

Acceptance publication date 22 February 2007

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

16 October 2003 Complete Application Filed

6 November 2003 Application Open to Public Inspection

  Published as AU-B-2003252758

22 February 2007 Application Accepted

  Published as AU-B-2003252758

21 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003252759-Animal handling system

2003252757-Human Criptin Growth Factor